| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Carcinoma, Non-Small-Cell Lung | 14 | 2021 | 896 | 3.11 | Why? |
| Lung Neoplasms | 16 | 2021 | 3228 | 2.25 | Why? |
| Small Cell Lung Carcinoma | 3 | 2021 | 133 | 2.14 | Why? |
| Protein Kinase Inhibitors | 8 | 2018 | 1585 | 1.10 | Why? |
| ErbB Receptors | 5 | 2018 | 320 | 0.94 | Why? |
| Aryldialkylphosphatase | 2 | 2018 | 61 | 0.92 | Why? |
| Intestine, Large | 1 | 2021 | 52 | 0.92 | Why? |
| Bed Rest | 3 | 2018 | 22 | 0.92 | Why? |
| Antineoplastic Agents | 6 | 2021 | 3550 | 0.86 | Why? |
| Pneumonectomy | 2 | 2021 | 278 | 0.85 | Why? |
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 36 | 0.75 | Why? |
| Ileum | 1 | 2021 | 233 | 0.75 | Why? |
| Panniculitis | 1 | 2018 | 13 | 0.73 | Why? |
| Exons | 1 | 2018 | 158 | 0.72 | Why? |
| Fatty Acid-Binding Proteins | 1 | 2018 | 93 | 0.70 | Why? |
| Organophosphorus Compounds | 1 | 2017 | 53 | 0.70 | Why? |
| Lipoproteins | 1 | 2018 | 240 | 0.66 | Why? |
| Lipocalin-2 | 1 | 2018 | 156 | 0.64 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2021 | 2984 | 0.63 | Why? |
| Subcutaneous Fat | 1 | 2017 | 94 | 0.62 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 133 | 0.62 | Why? |
| Drug Resistance, Neoplasm | 6 | 2018 | 447 | 0.60 | Why? |
| Immunotherapy | 3 | 2019 | 2421 | 0.59 | Why? |
| Radiotherapy | 1 | 2021 | 608 | 0.59 | Why? |
| Dyslipidemias | 1 | 2021 | 791 | 0.54 | Why? |
| Ischemia | 1 | 2021 | 901 | 0.51 | Why? |
| Muscle, Skeletal | 2 | 2018 | 915 | 0.51 | Why? |
| Pyrimidines | 2 | 2017 | 1557 | 0.48 | Why? |
| Mutation | 7 | 2018 | 12376 | 0.45 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.45 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 1510 | 0.38 | Why? |
| Fibrinolytic Agents | 1 | 2021 | 1702 | 0.38 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.37 | Why? |
| Cognition | 2 | 2018 | 1394 | 0.36 | Why? |
| Transcriptome | 2 | 2018 | 3466 | 0.33 | Why? |
| Receptor Protein-Tyrosine Kinases | 2 | 2017 | 243 | 0.31 | Why? |
| Lower Extremity | 3 | 2021 | 593 | 0.31 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.29 | Why? |
| Disease-Free Survival | 3 | 2021 | 1654 | 0.29 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.28 | Why? |
| Italy | 13 | 2021 | 38444 | 0.27 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.27 | Why? |
| Neoplasm Staging | 3 | 2020 | 1999 | 0.26 | Why? |
| HLA-G Antigens | 1 | 2021 | 48 | 0.22 | Why? |
| Drug Chronotherapy | 1 | 2020 | 33 | 0.21 | Why? |
| Alzheimer Disease | 3 | 2018 | 1020 | 0.20 | Why? |
| Ultrasonography, Doppler, Duplex | 1 | 2021 | 168 | 0.20 | Why? |
| Receptors, Purinergic P2X7 | 1 | 2019 | 35 | 0.19 | Why? |
| Ceruloplasmin | 1 | 2018 | 12 | 0.19 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 1573 | 0.19 | Why? |
| Osteoporotic Fractures | 1 | 2021 | 175 | 0.19 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.19 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 47 | 0.18 | Why? |
| Necrosis | 1 | 2021 | 532 | 0.18 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.18 | Why? |
| Dementia, Vascular | 1 | 2018 | 33 | 0.18 | Why? |
| Carboxylic Ester Hydrolases | 1 | 2017 | 16 | 0.18 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 130 | 0.18 | Why? |
| Sulfones | 1 | 2017 | 66 | 0.17 | Why? |
| Chemoradiotherapy | 1 | 2020 | 362 | 0.17 | Why? |
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3633 | 0.17 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.17 | Why? |
| Glucuronidase | 1 | 2018 | 103 | 0.17 | Why? |
| Radiosurgery | 1 | 2020 | 249 | 0.17 | Why? |
| Health Status Indicators | 1 | 2020 | 341 | 0.16 | Why? |
| Humans | 44 | 2021 | 930598 | 0.16 | Why? |
| Neoplastic Stem Cells | 1 | 2018 | 120 | 0.16 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.16 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.16 | Why? |
| Thoracic Neoplasms | 1 | 2020 | 343 | 0.15 | Why? |
| Reverse Transcriptase Inhibitors | 1 | 2018 | 309 | 0.15 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.15 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.15 | Why? |
| Osteoporosis | 1 | 2021 | 410 | 0.15 | Why? |
| STAT3 Transcription Factor | 1 | 2017 | 268 | 0.15 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.15 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Muscle Strength | 1 | 2018 | 317 | 0.15 | Why? |
| Case-Control Studies | 6 | 2021 | 17671 | 0.15 | Why? |
| Male | 27 | 2021 | 367725 | 0.14 | Why? |
| Resistance Training | 1 | 2018 | 273 | 0.14 | Why? |
| Multivariate Analysis | 3 | 2021 | 5440 | 0.14 | Why? |
| Pyridines | 2 | 2017 | 680 | 0.14 | Why? |
| Internal Medicine | 1 | 2020 | 557 | 0.14 | Why? |
| Intra-Abdominal Fat | 1 | 2017 | 227 | 0.14 | Why? |
| Body Composition | 1 | 2018 | 414 | 0.13 | Why? |
| Energy Metabolism | 1 | 2018 | 451 | 0.13 | Why? |
| Cholesterol, HDL | 1 | 2017 | 439 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.13 | Why? |
| Decision Support Systems, Clinical | 1 | 2019 | 551 | 0.13 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.13 | Why? |
| Medical Oncology | 2 | 2020 | 3826 | 0.13 | Why? |
| Aged | 19 | 2021 | 215776 | 0.13 | Why? |
| Oncologists | 1 | 2020 | 877 | 0.12 | Why? |
| Female | 24 | 2021 | 380317 | 0.12 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.12 | Why? |
| Organ Specificity | 1 | 2017 | 1070 | 0.12 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.12 | Why? |
| Surgical Oncology | 1 | 2020 | 923 | 0.12 | Why? |
| Radiation Oncology | 1 | 2020 | 834 | 0.12 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.11 | Why? |
| Netherlands | 1 | 2021 | 3533 | 0.11 | Why? |
| Oxidative Stress | 2 | 2018 | 2050 | 0.10 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| C-Reactive Protein | 4 | 2021 | 7972 | 0.10 | Why? |
| Biomarkers | 6 | 2021 | 23361 | 0.10 | Why? |
| Pyrazoles | 2 | 2017 | 1791 | 0.10 | Why? |
| Aged, 80 and over | 11 | 2021 | 88759 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.10 | Why? |
| Drug Approval | 1 | 2019 | 1325 | 0.10 | Why? |
| Cognitive Dysfunction | 2 | 2018 | 1389 | 0.10 | Why? |
| Disease Progression | 4 | 2021 | 13580 | 0.09 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.09 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Risk Assessment | 3 | 2021 | 25439 | 0.09 | Why? |
| Gene Rearrangement | 2 | 2018 | 84 | 0.09 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.09 | Why? |
| Blood Gas Analysis | 2 | 2021 | 893 | 0.08 | Why? |
| Adult | 11 | 2021 | 244371 | 0.08 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.08 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.07 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.07 | Why? |
| B7-H1 Antigen | 2 | 2018 | 541 | 0.07 | Why? |
| Dementia | 1 | 2018 | 1861 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| United States | 2 | 2021 | 46150 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Comorbidity | 3 | 2021 | 34796 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Animals | 5 | 2018 | 78931 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.06 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.06 | Why? |
| Antibodies, Monoclonal | 2 | 2017 | 8041 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2021 | 107 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Exercise | 2 | 2018 | 6771 | 0.05 | Why? |
| Quality of Life | 2 | 2021 | 9820 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Registries | 1 | 2020 | 12327 | 0.05 | Why? |
| Medical Futility | 1 | 2021 | 150 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Body Weights and Measures | 1 | 2018 | 50 | 0.05 | Why? |
| Tumor Escape | 1 | 2017 | 36 | 0.04 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2018 | 75 | 0.04 | Why? |
| Immobilization | 1 | 2018 | 74 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2021 | 1256 | 0.04 | Why? |
| Homocysteine | 1 | 2018 | 83 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2018 | 207 | 0.04 | Why? |
| Blood Vessels | 1 | 2019 | 228 | 0.04 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.04 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.04 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.04 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.04 | Why? |
| China | 2 | 2021 | 50654 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2018 | 264 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2019 | 294 | 0.04 | Why? |
| Electromyography | 1 | 2018 | 278 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| CTLA-4 Antigen | 1 | 2017 | 282 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Environmental Microbiology | 1 | 2020 | 575 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.03 | Why? |
| Disability Evaluation | 1 | 2018 | 671 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.03 | Why? |
| Compassionate Use Trials | 1 | 2017 | 632 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.03 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2017 | 724 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.03 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.03 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.02 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.01 | Why? |